Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells

Ovarian cancer is an aggressive and lethal cancer usually treated by cytoreductive surgery followed by chemotherapy. Unfortunately, after an initial response, many patients relapse owing mainly to the development of resistance against the standard chemotherapy regime, carboplatin/paclitaxel, which i...

Descripción completa

Detalles Bibliográficos
Autores principales: Catanzaro, Daniela, Nicolosi, Silvia, Cocetta, Veronica, Salvalaio, Marika, Pagetta, Andrea, Ragazzi, Eugenio, Montopoli, Monica, Pasut, Gianfranco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908290/
https://www.ncbi.nlm.nih.gov/pubmed/29682189
http://dx.doi.org/10.18632/oncotarget.24708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908290/
https://www.ncbi.nlm.nih.gov/pubmed/29682189
http://dx.doi.org/10.18632/oncotarget.24708

Ejemplares similares